MARKET

NUVB

NUVB

Nuvation Bio Inc
NYSE
2.260
+0.020
+0.89%
Closed 19:41 05/16 EDT
OPEN
2.240
PREV CLOSE
2.240
HIGH
2.290
LOW
2.201
VOLUME
1.80M
TURNOVER
0
52 WEEK HIGH
3.970
52 WEEK LOW
1.540
MARKET CAP
768.99M
P/E (TTM)
-0.9642
1D
5D
1M
3M
1Y
5Y
1D
Is Nuvation Bio (NYSE:NUVB) Using Debt In A Risky Way?
Simply Wall St · 1d ago
Nuvation Bio Price Target Maintained With a $5.00/Share by Wedbush
Dow Jones · 2d ago
Wedbush Reiterates Outperform on Nuvation Bio, Maintains $5 Price Target
Benzinga · 2d ago
Nuvation Bio (NUVB) Gets a Buy from Wedbush
TipRanks · 2d ago
Analysts Offer Insights on Healthcare Companies: Nuvation Bio (NUVB), Lucid Diagnostics (LUCD) and Arcellx Inc (ACLX)
TipRanks · 3d ago
Nuvation Bio’s Positive Outlook: Taletrectinib Approval and Financial Strength
TipRanks · 6d ago
Tracking David Abrams' Abrams Capital Management Portfolio - Q1 2025 Update
Seeking Alpha · 6d ago
Nuvation Bio to Participate in Upcoming Investor Conferences
Barchart · 6d ago
More
About NUVB
Nuvation Bio Inc. is a global biopharmaceutical company. The Company is engaged in tackling the unmet needs in oncology by developing differentiated and therapeutic candidates. Its programs include taletrectinib (ROS1 inhibitor), safusidenib (mIDH1 inhibitor), NUV-1511 (drug-drug conjugate), and NUV-868 (BET inhibitor). The Company's Taletrectinib is an oral, potent, central nervous system-active, selective, ROS1 inhibitor specifically designed for the treatment of patients with ROS1-positive (ROS1+) non-small cell lung cancer (NSCLC). Safusidenib is a novel, oral, potent, brain penetrant, targeted inhibitor of mutant mutant isocitrate dehydrogenase 1(mIDH1). NUV-1511, a clinical-stage drug-drug conjugate (DDC), fuses a targeting agent to a widely used chemotherapy agent. Its NUV-868 is a BD2-selective, oral, small molecule bromodomain and extra-terminal (BET) inhibitor that inhibits BRD4.

Webull offers Nuvation Bio Inc stock information, including NYSE: NUVB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NUVB stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NUVB stock methods without spending real money on the virtual paper trading platform.